Nuvasive Inc. scored a win at the FDA, with the agency clearing its Pulse surgical automation platform. It is the first integrated spine surgery automation platform from the company, and it is intended to be the foundation for Surgical Intelligence, an effort to enable better surgery. Pulse brings together 2D and 3D navigation, smart imaging capabilities, as well as neuromonitoring, surgical planning, radiation reduction and patient-specific rod bending technologies. Read More
